Company intelligence / Profile preview

SpineSave

Embrach, Zurich (ZH), Switzerlandspinesave.com ↗

Ownership: Private
Development stage: Commercial

Overview

SpineSave develops and markets the SpineShape System IV, a dynamic stabilization implant system for the lumbar spine, offering an alternative to spinal fusion surgery. The system has been in use since 2013 with reported positive clinical outcomes for motion preservation and pain reduction[1][2].

Therapeutic areas: Neurology
Modalities: Device
Industry: Implantable Medical Devices

Drug pipeline

1 asset

SpineShape System IV

Commercial

Indications: Degenerative scoliosis, Adjacent segment syndrome, Facet joint syndrome, Dynamic stenosis, Disc herniation

Partnerships

Diener Precision Machining

Beyond the preview

Go deeper on SpineSave.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SpineSave.

Explore the full profile